




Please do not adjust margins 
Please do not adjust margins 
Received 00th February 20xx, 
Accepted 00th February 20xx 
DOI: 10.1039/x0xx00000x 
 
A QM/MM Study on the Origin of Retro-Aldolase Activity of a 
Catalytic Antibody.  
Daria De Raffele,a Sergio Martí a and Vicent Moliner *a 
The retro-aldolase mechanism of methodol catalysed by the 
catalytic antibody 33F12 is described based on the exploration of 
the free energy landscape obtained with QM/MM methods. The 
amino acids involved in the reaction have been identified, as well 
as their specific role played in the active site and in the flexibility of 
the loops. Finally, the comparison with a de novo enzyme RA95.5-
8F provides a deeper understanding of catalytic differences  
between such diferent protein scaffolds. 
In 1986 Richard A. Lerner and Alfonso Tramontano began their 
article Catalytic Antibodies (CAs) making the question: “Can 
antibodies be made to serve as enzymes?”.1 After only five 
years from the publication of this article, a substantial number 
of reactions were successfully catalysed by antibodies: 
carbonate hydrolysis, ester hydrolysis, Claisen rearrangement, 
transesterification or Diels-Alder reactions, just to mention 
some of them.2 The capability to produce such CAs comes from 
the proper design of a stable molecule, which must resemble 
the structure of the transition state (TS) of the chemical reaction 
(transition state analogue, TSA). Then, the TSA is used as a 
hapten to challenge an immune system, which replies 
generating a germline antibody that will bind it and, hopefully, 
it would also present affinity for the real TS. An affinity 
maturation process is followed, where catalytic groups can be 
introduced directly by chemical modification or by site-directed 
mutagenesis or genetic selection, to lead to a high affinity 
monoclonal matured antibody with catalytic properties.3 
Nevertheless, two serious drawbacks appear: first, because the 
TSA does not correspond to the real protein–substrate TS, the 
specific pattern of interactions established with the CA does not 
exactly match to the one found in the TS; and second, it has 
been claimed that the high binding affinity developed by the 
antibody during its maturation against the TSA molecule provides an 
excessive rigidity to the Michaelis complex, which translates into a 
loss of plasticity compared to natural enzymes. These limitations 
can be in the origin of the usually low efficiency of the CAs, 
which combined with the poor knowledge of the molecular 
mechanism of the chemical reactions inside the protein4–7, 
hamper the progress in the application of CAs as catalysts. 
Anyway, due to the ability to yield antibodies tailored for any 
specific reaction, they have been widely studied for different 
purposes ranging from therapeutic or diagnostic agents to the 
creation of novel materials.8,9 Originally, the existence of 
enzymes that catalyse the aldol condensation was well known, 
despite with a limited number of substrates. In 1995 Barbas III 
and co-workers published a study which goal was to generate 
CAs to catalyse the aldol reaction by means of the mechanism 
used by natural class I aldolase enzymes, but with the 
availability of using different substrates.10 Out of 20 antibodies 
screened, two of them, 38C2 and 33F12, presented not only 
aldolase catalytic activity but they were able to catalyse over 
100 different reactions, including retro-aldol, and enamine / 
iminium-based transformations of a very wide range of substra-
tes and stereochemical specificities.10,11 In order to better 
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Fig. 1 Representation of the X-ray structure of L (magenta) and H 
(green) chains of 33F12 and detail of the active site in VDW 
representation refers to residues that take part in the reaction. 
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understand the structural features of the active site of these 
two sequence-related variants, both CAs were cloned and their 
genes sequenced.11 The results revealed that the two CAs were 
somatic variants of a single VDJ rearrangement and differed by 
just nine amino acids each in the two variable regions VL and 
VH.11 The analysis of the X-ray crystal structure of 33F12 showed 
that the entry is a narrow-elongated cleft, and the binding 
pocket is more than 11 Å deep. The reactive Lys93:H is located 
at the bottom of the pocket, within a hydrophobic environment. 
Apparently, the absence of charged functional groups or hydro-
gen bonds in the surroundings of Lys93:H promotes its 
deprotonated state making it a strong nucleophile.12 In the 
present work, the retro-aldol reaction of the non-natural 
substrate 4-hydroxy-4-(6-methoxy-2-naphthyl)-2-butanone 
(methodol) catalysed by CA 33F12 (see Fig. 1), whose full X-ray 
structure is avaliable,13 is carried out by means of Quantum 
Mechanics/Molecular Mechanics (QM/MM) methods. It is 
important to point out that despite there are no evidences on 
the ability of 33F12 to discriminate between enantiomeric 
substrates, either 38C2 and the de novo enzymes explored in 
our previous studies14,15 show (R) stereospecificity. The choice 
of the retro-aldol conversion lies in its broad used in 
biochemical syntheses because of the carbon-carbon bond 
breaking availability and the fact that there is no natural enzyme 
known that catalyses this reaction. In addition, many efforts 
have been directed to designing new enzymes with retro-aldol 
activity, which will allow carrying out comparisons between CA 
and de novo designs. In this regard, Baker et al. in 2008 designed 
a total of 72 enzymes, 32 of which showed retro-aldol catalytic 
activity against methodol16. Indeed, the best resulting enzyme, 
RA95.5-8F, showed rate enhancements of up to 109 over the 
uncatalyzed reaction.17 This discovery led to several studies to 
detect its chemical, thermodynamic and kinetic characte-
ristics.14,18,19 Notwithstanding, practically all de novo enzymes 
are still far from resembling the catalytic skills of their natural 
counterparts. The study of CAs, based on a completely different 
protein scaffold, can also be useful to improve not only their  
own catalytic efficiency but can provide information to improve 
de novo enzymes. Our results will allow identifying the overall 
molecular mechanism, and investigating the role played by the 
key amino acids that participate in the reaction. Moreover, a 
deep comparative analysis with the results previously obtained 
for the same reaction catalysed by the de novo RA95.5-8F 
enzyme (Fig. S3) will provide valuable information for future 
designs.14,15,20 From the mechanistic point of view, the main 
feature of this chemical process is the presence of several 
successive steps, each one demanding acid-base catalysis. Thus, 
the catalyst must be structurally and electrostatically adapted 
to each transition state and intermediate in order to improve 
the kinetic of the overall reaction. The reaction mechanism we 
propose (Fig. 2) is based on our previous computational studies 
of the same reaction catalysed by two de novo protein designs, 
RA95.5-5 and RA95.5-8F.14,15 The resulting DFT/MM free energy 
profile is depicted in Fig. 3, where the one previously obtained 
for the same reaction catalyzed by RA95.5-8F de novo enzyme14 
is also shown. As schematically shown in Fig. 2 (see Fig. S1 for 
atom labeling), the first step of the reaction involves the attack 
to the carbonyl carbon of the substrate by nitrogen of the 
Lys93:H (NK93) leading to the formation of a metastable 
zwitterion I1. This intermediate is mainly stabilized by the 
interaction of the partial charge formed on the NK93 with the 
aromatic ring of the Phe98:L, with the Trp103:H, and through 
an hydrogen bond interaction between O1 and the hydroxyl 
group of Tyr36:L. In the second step, the hydrogenation of the 
carbonyl oxygen of the substrate to form the alcohol takes 
place. The formation of the intermediate I2 is characterized by 
the presence of an alkoxide in Tyr36:L which interacts with one 
of the hydrogen atoms of the Lys93:H cation and with the 
Trp103:H amino group. The third step involves the 
deprotonation of the Lys93:H by the Tyr36:L leading to a 
carbinolamine intermediate (I3). This step is strongly exergonic 
in both catalysts, being I3 particularly stable in the CA (-18.1 kcal 
mol-1), and with a relative activation free energy barrier of just 
5.5 kcal mol-1. This hydrogen transfer is associated with the 
formation of the NK93-C2 bond, along with the recovery of the 
neutral charge which appears to play a key role in the stability 
of the carbinolamide. The fourth step corresponds to the 
formation of the first product of the reaction, the 6-methoxy-2-
naphthylacetic acid (6-MNA), and an enamine intermediate (I4). 
Fig. 3 M062X/6-31+G(d,p):AM1/MM free energy profile for the 
reaction mechanism of the Retro-Aldol reaction of the (R)-methodol 
enantiomer catalyzed by catalytic antibody 33F12 (red line) and by 
RA95.5-8F (blue line). RA95.5-8F profile is derived from ref. 14. 
Fig. 2 Schematic representation of the proposed reaction mechanism 
of the retro-aldol reaction on methodol, catalyzed by the catalytic 
antibody 33F12.  
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The reaction involves the deprotonation of the hydroxyl group 
of the substrate (O2) by Tyr36:L, the breaking of the C3-C4 bond 
of the substrate and the formation of a water molecule. The 
analysis of the geometries suggests that the transition state is 
assisted by the residues Trp103:H, Phe98:L and Asn34:L. This 
step has been traditionally the rate-determining step of the de 
novo enzymes 15,21 with the exception of the RA95.5-8F14,19,22, 
whose catalytic tetrad creates a hydrogen-bonding network 
able to enhance the kinetic of this step. The high value observed 
in the energy barrier for the CA (18.6 kcal mol-1) could be 
ascribed to the absence of this organized network of polar 
residues in the active site. In the fifth step, the proton on 
Tyr36:L is transferred to the nucleophilic sp2 carbon atom (C3) 
of the enamine compound, to form the intermediate iminium 
Schiff base (I5). The stability of the intermediate I5 is due to the 
electrostatic interaction of the Schiff base with Asn34:L and 
Ser100:H, and the interaction of the negative charged Tyr36:L 
with Trp103:H. This is the rate-determining step of the overall 
reaction in both the CA and the RA95.5-8F de novo enzyme, 
although the catalytic efficiency of the latter is clearly higher 
than that found for the CA. The free energy value obtained for 
this step in the CA is 27.6 kcal mol-1, which appear to be slightly 
overestimated by comparison with the experimental value 
(21.5 kcal mol-1).23 Nevertheless, our value is computed with 
respect intermediate I3, which can be overstabilized. The energy 
difference between the rate limiting TS5 and reactants is 22.5 
kcal mol-1, which would be in very good agreement with the 
experimental data. The nucleophilic attack of the water 
molecule and the reestablishment of the electroneutrality takes 
place in the sixth step, leading to the formation of the 
carbinolamine species (intermediate I6). In the seventh step, 
the Tyr36:L behaves, like in TS3, as both acid and basic species: 
it transfers a proton to the Lys93:H, promoting the breaking of 
the NK93-C2 bond; and withdraws the hydrogen from the 
hydroxyl group (O1), yielding the acetone molecule, and 
restoring the CA. The last transition state is stabilized by 
interactions with Trp103:H.  
The comparative analysis between the de novo RA95.5-8F and 
the CA 33F12 shows how the former requires less chemical 
steps than the later. Thus, the CA needs two steps to reach I2 
intermediate while the same transformation is concerted in the 
RA95.5-8F enzyme. Nevertheless, the activation free energy of 
both systems only differs 0.2 kcal mol-1, and I1 in the CA is not 
kinetically relevant (according to the low energy barrier for the 
reverse decomposition into reactants). The opposite behaviour 
is observed in the transformation from the Schiff base, I5, to the 
carbinolamine I6 intermediate; the CA catalyzes this 
transformation in one single step while in the de novo enzyme 
it requires two step. It is remarkable nevertheles, how the 
former is clearly more efficient than the CA, according to the 
lower energy barriers. Overall, the reaction is an endergonic 
process in the CA (the product energy value is 6.7 kcal mol-1 
higher than the reactants), while it is almost thermoneutral in 
the de novo RA95.5-8F14,15 enzyme. The activation interaction 
energy decomposed by the contribution of each residue for the 
key chemical steps are shown in Figure 4 (see Supporting 
Information for details). These contributions are expressed as 
the difference of the electrostatic and Lennard-Jones 
interaction energies between the substrate and the protein, per 
residue, between each TS and its preceding intermediate. 
Analysis of these plots allows identifying and confirming the role 
that each amino acid plays in the catalytic process. As can be 
seen, the first step of the reaction in the CA (TS1) is stabilized by 
the interaction with the residues Ser89:L, Ser35:H and 
Trp103:H, in opposition to the Ser100:H residue which 
disfavours/destabilizes the conversion. The second step (TS2) is 
mainly favoured by the interaction with the residue Trp103:H, 
which plays a predominant role in this step and, to a lesser 
extent, by the residues Glu6:H and Glu50:H. On the other hand, 
a quite strong unfavourable interaction with Ser100:H is still 
present. The favourable interaction with the Trp103:H remains 
in the fourth step (TS4), accompanied by a strong effect of the 
Glu6:H. Arg52:H together with Asp58:H and Ser100:H, clearly 
disfavour the reaction by stabilizing the intermediate I3 with 
respect to TS4. Finally, several unfavourable interactions can be 
identified for the fifth step (TS5), such as Phe87:L, Arg52:H and 
Ser100:H, responsible for stabilizing the intermediate I4 with 
respect to TS5. Trp103:H, which assisted the reaction in the first 
Fig. 4 Averaged substrate-protein activation interaction energies for 
the key steps of retro-aldol reaction catalyzed by 33F12. Only are 
displayed those residues showing interaction energies higher than 1 




Fig. 5. a) de novo RA95.5-8F, in dark orange loop L1 and in sandy 
brown loop L6. b) Catalytic antibody 33F12, loop H1 is in dark blue, 
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steps, together with Glu6:H, Glu50:H and Ser89:L stabilize the 
transition state. The evaluation of these results with the 
previously reported for the de novo RA95.5-8F enzyme14, allows 
to identify the role played by key residue in both systems. 
Interestingly, the comparison of the RMSD for the loops located 
in the active site (see Fig. 5) shows less movement in the CA 
than in the de novo enzyme throughout the key steps of the 
reaction (Fig. S10). This factor, together with the greater 
accessibility of the enzyme active site, entails a more favorable 
formation and removal of the product 6-MNA in the later. In 
addition, the deeply buried hydrophobic pocket of the 33F12, 
provides more stability to the neutrally charged intermediate I3, 
the carbinolamine, that in turn provokes higher energy barrier 
for its decomposition. 
In conclusion, the exploration of the retro-aldolase reaction 
catalysed by the CA 33F12 Fab’ by means of QM/MM MD 
simulations allowed obtaining the complete free energy 
landscape and determining the molecular mechanism of the 
complex multi-step reaction. Analysis of electrostatic and 
Lennard-Jones interactions between the protein and the 
substrate in the key states of the process sheds light on the role 
played by the different residues of the active site. The obtained 
reaction mechanism is comparable to the one previously 
computed for the same reaction catalysed by the de novo 
design RA95.5-8F, but with noticiable differences. Thus, the first 
step in the de novo enzyme takes place in two steps in the CA 
catalysed reaction, while the opposite scenario is observed in 
the formation of the Schiff base from the protonation of the 
enamine, which takes place in two steps in the de novo enzyme 
and in a concerted manner in the CA. In fact, this is the rate 
limiting step of the full retro-aldol reaction catalysed by the CA. 
The activation free energy of this step appears to be slightly 
overestimated, by comparison with the available experimental 
data. Nevertheless, the lower catalytic efficiency of this 
biocatalyst, by comparison with the de novo design RA95.5-8F, 
reproduces the experimental kinetic trend. Our results show 
how Trp103:H, Glu50:H and Glu6:H are crucial to stabilize the 
TSs of the three key steps in the reaction. The hydrophobic 
microenvironment accounts for the pKA of the ε-amino group of 
the active site Lys93:H,10 as in the de novo enzyme.24 This 
confirms similar strategies adopted by both kind of catalysts. 
This work is a dowel in the study of the retro-aldol catalysts, and 
thereof it is possible to deduce information to propose new 
mutations able to improve de novo designed enzymes. 
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